A Phase 1 Study to Assess Radiation Biodistribution, Dosimetry, Pharmacokinetics and Safety of GEH300079 (68Ga) Injection and Determine the Optimal Injected Activity and Timing of PET/CT Imaging in Patients with Peritoneal Carcinomatosis of Colorectal, Gastric, Pancreatic or Ovarian Origin

Start 28 Apr 2026 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol GE-282-101

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other

Status Ongoing, recruiting

Participants planned 16

Countries 1

Sites 1

Peritoneal Carcinomatosis of Colorectal,Gastric, Pancreatic or Ovarian Origin

Key facts

Sponsor: GE Healthcare Limited
Participant type: Patients
Age range: 18-64 years, 65+ years
Gender: Male and Female
Therapeutic area: Diseases [C] - Neoplasms [C04]
Trial duration: 28 Apr 2026 → ongoing
Decision date (initial): 2026-02-24
Transition trial: No
Low-intervention: No
Rare-disease indication: Yes
Vulnerable population: Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Peritoneal Carcinomatosis of Colorectal,Gastric, Pancreatic or Ovarian Origin

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

GE Healthcare Limited

Sponsor organisation: GE Healthcare Limited
Address: Pollards Wood, Nightingales Lane Nightingales Lane
City: Chalfont St. Giles
Postcode: HP8 4SP
Country: United Kingdom

Scientific contact point

Organisation: GE Healthcare Limited
Contact name: Aimee Liu, MD

Public contact point

Organisation: GE Healthcare Limited
Contact name: Shoma Das

Locations

1 EU/EEA country · 1 investigational sites

By country

Country	MS status	Planned subjects	Sites
Sweden	Ongoing, recruiting	16	1
Rest of world	—	0	—

Investigational sites

Sweden

1 site · Ongoing, recruiting

Karolinska University Hospital

Karolinska universitetssjukhuset i Huddinge Enheten för radiologi/ Avdelningen för nuklearmedicin, Halsovagen, Flemingsberg, Huddinge

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country	Trial start	Trial end	Recruitment start	Recruitment end	Early termination
Sweden	2026-04-28		2026-04-28

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#	Type	Code	Submitted	Reference MS	Conclusion	Decision date
1	INITIAL	IN	2025-12-15	Sweden	Acceptable 2026-02-23	2026-02-24